SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $31,028,000 | +9.2% | 1,228,844 | +6.9% | 0.01% | +25.0% |
| Q3 2016 | $28,421,000 | +41.8% | 1,149,244 | +16.8% | 0.00% | +33.3% |
| Q2 2016 | $20,042,000 | +48.4% | 983,898 | +11.1% | 0.00% | +50.0% |
| Q1 2016 | $13,509,000 | +15.0% | 885,841 | +1.4% | 0.00% | 0.0% |
| Q4 2015 | $11,743,000 | -0.6% | 873,768 | +3.8% | 0.00% | 0.0% |
| Q3 2015 | $11,809,000 | +14.8% | 841,665 | +38.9% | 0.00% | 0.0% |
| Q2 2015 | $10,289,000 | +126.7% | 605,970 | +61.4% | 0.00% | +100.0% |
| Q1 2015 | $4,539,000 | +97.3% | 375,432 | +35.5% | 0.00% | – |
| Q4 2014 | $2,300,000 | -5.6% | 277,133 | -1.1% | 0.00% | – |
| Q3 2014 | $2,436,000 | -27.2% | 280,327 | -8.3% | 0.00% | -100.0% |
| Q2 2014 | $3,348,000 | +93.0% | 305,740 | +57.5% | 0.00% | – |
| Q1 2014 | $1,735,000 | +55.5% | 194,071 | +31.1% | 0.00% | – |
| Q4 2013 | $1,116,000 | -2.0% | 148,026 | -4.8% | 0.00% | – |
| Q3 2013 | $1,139,000 | +19.1% | 155,442 | +4.6% | 0.00% | – |
| Q2 2013 | $956,000 | – | 148,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |